Dr. Ratri Wulandari

Junior staff in the Department of Obstetrics and Gynaecology, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada.

Previous experience:
My research interest lies within the field of Gynecologic oncology, in particular, ovarian cancer. Therefore, I joined Department of Obstetrics and Gynecology, UGM as a Junior Academic Staff after graduated from Faculty of Medicine, UGM. The interest in woman’s cancer was first developed during my undergraduate programme and further solidified during my MSc in Reproductive Science and Women’s Health, UCL. I successfully completed the MSc with a dissertation project under Dr John Timms supervision in the Cancer Proteomics Laboratory. The research used ELISA to measure the concentration of AGR2 in pre-diagnostic serum samples from UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS). I gained a Distinction for this course, and I was also given the opportunity to present my research findings at the Asian Oncology Summit 2014. Getting involved in UKCTOCS makes me interested in cancer epidemiology. Thus I applied and selected to participate in the Summer School in Introduction to Cancer Epidemiology held by International Agency for Research on Cancer (IARC-WHO) prior to my PhD. In addition, I also ever involved in Fluid and Nutrients Intake Study of Indonesian Pregnant And Lactating Women in Jakarta, Yogyakarta and Surabaya, in collaboration with DANONE Multicenter study in Indonesia.

Educational background:
October 2014 – October 2018 (expected)
PhD in Clinical Medicine Research (Surgery and Cancer)
Imperial College London, UK
Supervisors : Prof Christina Fotopoulou & Dr Paula Cunnea
Project title: Functional tumour heterogeneity in advanced ovarian cancer
High-grade serous ovarian cancer is the most lethal gynecologic malignancy. It is characterised by high degrees of genomic instability and heterogeneity, with many patients initially responding to chemotherapy but ultimately relapse with the development of resistance to platinum chemotherapy. The diversity in platinum resistance mechanisms and complete lack of predictive biomarkers means delivering the best treatment for ovarian cancer patients remains challenging. The aim of this study is to understand the extent of intra-tumour heterogeneity (ITH) in advanced high grade serous ovarian cancer, to describe the molecular mechanisms behind peritoneal dissemination of the disease and to define the
link between ITH at the molecular and phenotypic levels.

September 2012 – September 2013
Master of Science in Reproductive Science and Women’s Health
University College London, London, UK
Grade: Distinction (Cum Laude)
Modules taken: Basic genetics and technology; Gametogenesis, Preimplantation development and IVF; Female reproductive anatomy and physiology, Pregnancy and childbirth; Prenatal diagnosis and screening; Reproductive health; Breast and Reproductive Cancers; Preimplantation genetic diagnosis
Research Project : Testing AGR2 as an Early Cancer Biomarker.

April 2009 – October 2010
Medical Doctor
Faculty of Medicine, Universitas Gadjah Mada (UGM), Indonesia
GPA: 3.76 out of 4 (Cum Laude)

September 2005 – May 2009
Bachelor of Medicine
Faculty of Medicine, UGM, Indonesia
GPA: 3.82 out of 4 (Cum Laude)

Inspirational motto or quote:
“Man Jadda Wa Jadda” which mean whoever strives shall succeed

Aspirations after completing the Health-I program:
To become a professional who can lead the development of stronger community health services based on research and relevant evidence as an important investment to improve health and welfare of Indonesia in the future

Leave a Reply